These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 15477098)

  • 21. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
    Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
    Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange.
    Lu X; Wintrode PL; Surewicz WK
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1510-5. PubMed ID: 17242357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the helical structure of the N-terminal region of Plasmodium falciparum merozoite surface protein 2 in fibril formation and membrane interaction.
    Zhang X; Adda CG; Low A; Zhang J; Zhang W; Sun H; Tu X; Anders RF; Norton RS
    Biochemistry; 2012 Feb; 51(7):1380-7. PubMed ID: 22304430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structures of amyloid fibrils formed by the prion protein derived peptides PrP(244-249) and PrP(245-250).
    Yau J; Sharpe S
    J Struct Biol; 2012 Nov; 180(2):290-302. PubMed ID: 22929126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of prion peptide structure and aggregation in toxicity and membrane binding.
    Rymer DL; Good TA
    J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils.
    Onoue S; Ohshima K; Debari K; Koh K; Shioda S; Iwasa S; Kashimoto K; Yajima T
    Pharm Res; 2004 Jul; 21(7):1274-83. PubMed ID: 15290870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
    Cobb NJ; Apetri AC; Surewicz WK
    J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites.
    Leffers KW; Schell J; Jansen K; Lucassen R; Kaimann T; Nagel-Steger L; Tatzelt J; Riesner D
    J Mol Biol; 2004 Nov; 344(3):839-53. PubMed ID: 15533449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-Assembly of Aβ40, Aβ42 and Aβ43 Peptides in Aqueous Mixtures of Fluorinated Alcohols.
    Pachahara SK; Adicherla H; Nagaraj R
    PLoS One; 2015; 10(8):e0136567. PubMed ID: 26308214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
    Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
    Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
    Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
    J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.
    Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
    Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
    Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
    Yamaguchi K; Matsumoto T; Kuwata K
    Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
    Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
    Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils.
    El-Agnaf OM; Bodles AM; Guthrie DJ; Harriott P; Irvine GB
    Eur J Biochem; 1998 Nov; 258(1):157-63. PubMed ID: 9851705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural properties of Gerstmann-Straussler-Scheinker disease amyloid protein.
    Salmona M; Morbin M; Massignan T; Colombo L; Mazzoleni G; Capobianco R; Diomede L; Thaler F; Mollica L; Musco G; Kourie JJ; Bugiani O; Sharma D; Inouye H; Kirschner DA; Forloni G; Tagliavini F
    J Biol Chem; 2003 Nov; 278(48):48146-53. PubMed ID: 12970341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
    Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
    Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.